- Home
- VTYX vs OGI Comparison
VTYX vs OGI Comparison
Compare VTYX & OGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VTYX
- OGI
- Stock Information
- Founded
- VTYX 2018
- OGI 2013
- Country
- VTYX United States
- OGI Canada
- Employees
- VTYX N/A
- OGI N/A
- Industry
- VTYX Medicinal Chemicals and Botanical Products
- OGI Biotechnology: Pharmaceutical Preparations
- Sector
- VTYX Health Care
- OGI Health Care
- Exchange
- VTYX Nasdaq
- OGI Nasdaq
- Market Cap
- VTYX 154.9M
- OGI 135.1M
- IPO Year
- VTYX 2021
- OGI N/A
- Fundamental
- Price
- VTYX $1.07
- OGI $1.04
- Analyst Decision
- VTYX Buy
- OGI
- Analyst Count
- VTYX 4
- OGI 0
- Target Price
- VTYX $11.33
- OGI N/A
- AVG Volume (30 Days)
- VTYX 731.3K
- OGI 650.5K
- Earning Date
- VTYX 05-08-2025
- OGI 05-13-2025
- Dividend Yield
- VTYX N/A
- OGI N/A
- EPS Growth
- VTYX N/A
- OGI N/A
- EPS
- VTYX N/A
- OGI N/A
- Revenue
- VTYX N/A
- OGI $115,451,336.00
- Revenue This Year
- VTYX N/A
- OGI $50.11
- Revenue Next Year
- VTYX N/A
- OGI $16.16
- P/E Ratio
- VTYX N/A
- OGI N/A
- Revenue Growth
- VTYX N/A
- OGI N/A
- 52 Week Low
- VTYX $1.07
- OGI $0.96
- 52 Week High
- VTYX $5.66
- OGI $2.37
- Technical
- Relative Strength Index (RSI)
- VTYX 23.19
- OGI 40.39
- Support Level
- VTYX $1.28
- OGI $0.96
- Resistance Level
- VTYX $1.37
- OGI $1.16
- Average True Range (ATR)
- VTYX 0.08
- OGI 0.06
- MACD
- VTYX -0.01
- OGI 0.01
- Stochastic Oscillator
- VTYX 0.00
- OGI 40.00
About VTYX Ventyx Biosciences Inc.
Ventyx Biosciences Inc is a clinical-stage biopharmaceutical company focused on advancing new therapies for millions of patients living with inflammatory diseases and autoimmune disorders. The company is developing a pipeline of novel small-molecule product candidates to address a range of inflammatory diseases. Its product candidate VTX958 is an oral, selective clinical-stage tyrosine kinase type 2 (TYK2) inhibitor designed to inhibit TYK2 without detectable inhibition of other Janus kinase (JAK) isoforms, which avoids toxicities associated with broader JAK inhibition and, thus, other JAK inhibitors.
About OGI Organigram Holdings Inc.
Organigram Global Inc is a licensed cultivator of cannabis and manufacturer of cannabis-derived goods in Canada. It is is focused on producing high-quality cannabis for adult recreational consumers. It has also developed and acquired a portfolio of legal adult-use recreational cannabis brands, including Edison, Holy Mountain, Big Bag O' Buds, SHRED, SHRED'ems, Monjour, Tremblant Cannabis, Trailblazer, BOXHOT and DEBUNK. Organigram operates facilities in Moncton, New Brunswick and Lac-Superieur, Quebec, with a dedicated edibles manufacturing facility in Winnipeg, Manitoba.